We are live on ! Find out more
CLVS

Clovis Oncology, Inc.
CLVS

Delisted

CLVS was delisted on the 20th of December, 2022.

Back to rankings

112 hedge funds and large institutions have $1.52B invested in Clovis Oncology, Inc. in 2013 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 60 increasing their positions, 21 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

186% more repeat investments, than reductions

Existing positions increased: 60 | Existing positions reduced: 21

11% more capital invested

Capital invested by funds: $1.36B → $1.52B (+$153M)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

3% less funds holding

Funds holding: 116 → 112 (-4)

16% less first-time investments, than exits

New positions opened: 21 | Existing positions closed: 25

34% less call options, than puts

Call options by funds: $9.63M | Put options by funds: $14.6M

Holders
112
Holders Change
-4
Holders Change %
-3.45%
% of All Funds
3.25%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
21
Increased
60
Reduced
21
Closed
25
Calls
$9.63M
Puts
$14.6M
Net Calls
-$4.98M
Net Calls Change
-$3.87M

Top Buyers

Rank Fund Capital Flow
1
PHS
PFM Health Sciences
California
+$30.3M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$28.3M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$16.1M
4
BBA
Baker Bros. Advisors
New York
+$12.5M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$12.1M

Top Sellers

Rank Fund Capital Flow
1
AllianceBernstein
AllianceBernstein
Tennessee
-$23.4M
2
Loomis, Sayles & Company
Loomis, Sayles & Company
Massachusetts
-$10.3M
3
PA
Perceptive Advisors
New York
-$8.93M
4
HM
HealthCor Management
New York
-$8.56M
5
BIM
Bogle Investment Management
Massachusetts
-$5.01M
Name Holding Trade Value Shares
Change 		Change in
Stake
PAI
26
Palo Alto Investors
California
$11.3M +$10.2M +186,900 New
JHIU
27
Janus Henderson Investors US
Colorado
$10.9M +$1.22M +22,464 +14%
Geode Capital Management
28
Geode Capital Management
Massachusetts
$9.1M +$2.92M +53,773 +55%
CCM
29
Consonance Capital Management
New York
$8.58M +$43.5K +800 +0.6%
WSA
30
Wall Street Associates
California
$7.5M +$2.39K +44 +0%
Goldman Sachs
31
Goldman Sachs
New York
$7.37M +$301K +5,537 +5%
CAM
32
Cormorant Asset Management
Massachusetts
$7.19M +$6.49M +119,300 New
Bank of New York Mellon
33
Bank of New York Mellon
New York
$6.23M +$1.22M +22,507 +28%
HM
34
HealthCor Management
New York
$5.94M -$8.56M -157,458 -62%
TCIM
35
TIAA CREF Investment Management
New York
$5.6M +$761K +13,994 +18%
TA
36
Teachers Advisors
New York
$5.54M +$3.84M +70,610 +332%
PCM
37
Pentwater Capital Management
Florida
$5.42M +$4.9M +90,000 New
PC
38
PointState Capital
New York
$4.52M +$544K +10,000 +15%
CS
39
Credit Suisse
Switzerland
$4.32M -$86.9K -1,597 -2%
GC
40
Guggenheim Capital
Illinois
$4.28M +$543K +9,982 +16%
JP Morgan Chase
41
JP Morgan Chase
New York
$4.1M -$593K -10,908 -14%
LCM
42
Laurion Capital Management
New York
$3.97M +$3.58M +65,892 New
Charles Schwab
43
Charles Schwab
California
$3.44M +$717K +13,181 +30%
Principal Financial Group
44
Principal Financial Group
Iowa
$3.35M +$408K +7,500 +16%
Deutsche Bank
45
Deutsche Bank
Germany
$3.33M -$1.71M -31,414 -36%
Susquehanna International Group
46
Susquehanna International Group
Pennsylvania
$3.1M +$2.52M +46,245 +880%
BIM
47
BlackRock Investment Management
Delaware
$2.96M +$233K +4,292 +10%
U
48
UBS
Switzerland
$2.9M +$2.21M +40,614 +536%
SFM
49
Sphera Funds Management
Israel
$2.71M +$2.45M +45,000 New
Invesco
50
Invesco
Georgia
$2.49M +$2.25M +41,330 New
1
2
3 4 5

CLVS Hedge Fund Activity: Q4 2013 in Review

112 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Clovis Oncology, Inc. (CLVS) for Q4 2013, worth a combined $1.52B — up 11% from $1.36B a quarter earlier.

Sellers outnumbered buyers: 25 funds closed out of CLVS and 21 opened new positions — a net loss of 4 holders — while 21 trimmed existing stakes and 60 added.

The largest buyer was PFM Health Sciences, adding an estimated $30.3M. The largest seller was AllianceBernstein, cutting an estimated $23.4M.

  • 112 institutional investors held Clovis Oncology, Inc. (CLVS) as of Q4 2013, down from 116 in Q3 2013.
  • Funds reported $1.52B of Clovis Oncology, Inc. stock for Q4 2013, up 11% quarter-over-quarter.
  • 21 funds opened new Clovis Oncology, Inc. positions in Q4 2013 and 25 closed out, a net change of -4 holders.
  • The largest Clovis Oncology, Inc. buyer in Q4 2013 was PFM Health Sciences, an estimated $30.3M added.
  • The largest Clovis Oncology, Inc. seller in Q4 2013 was AllianceBernstein, an estimated $23.4M sold.

Based on aggregated 13F filings for Q4 2013.